Faculty

R. Robert Auger, M.D.

Clinical Studies

A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants with Delayed Sleep-Wake Phase Disorder (DSWPD) (DSWPD) Rochester, Minn.
The primary purpose of this study is to assess the effects of a daily single oral dose of 20 mg tasimelteon compared to placebo on Sleep Onset (change from baseline) in participants over a 28-day period, as measured by sleep diary.
Chronotype Distribution in Major Depressive Disorder Rochester, Minn.
The purpose of this study is to determine the baseline chronotype patterns (with Morningness-Eveningness Questionnaire (MEQ) ) among inpatients with Major depressive disorder and then compare the chronotype distribution with the control group.
Glasses for Adolescent Delayed Sleep-Wake Phase Disorder (GLAD) Rochester, Minn.
The purpose of this study is to determine if evening amber glasses combined with stable wake times will show an increase in total sleep time (TST), and an advance in sleep onset times (shift earlier) compared to the control group.